Peptomyc — Series A · €4.2M

Peptomyc closed a €4.2M Series A led by Alta Life Sciences, which was that fund's first investment. Healthequity and business angels from the seed round invested again. The money went to industrial manufacturing of its Omomyc-based peptides, to bring them closer to clinical use. Some databases quote this round as about $5M.

LeadAlta Life Sciences RoundSeries A Announced6 Sep 2017 CityBarcelona SectorHealthtech & Bio · Biotech Source V

Something wrong? Suggest a correction →